Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (302K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Shore, P.
Right arrow Articles by Corcoran, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shore, P.
Right arrow Articles by Corcoran, L. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2002, Vol. 30, No. 8 1767-1773
© 2002 Oxford University Press

Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1

Paul Shore*, Wendy Dietrich1 and Lynn M. Corcoran1

School of Biological Sciences, University of Manchester, 2.205, Stopford Building, Oxford Road, Manchester M13 9PT, UK and 1Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria 3050, Australia

The POU domain transcription factor, Oct-2, is essential for the B cell-specific expression of CD36 in mouse B cells. In order to determine how Oct-2 mediates expression of CD36 in B cells, we cloned and analysed the mouse CD36 promoter. In contrast to the human CD36 promoter, the mouse promoter contains a consensus octamer element of the type ATGCTAAT. This octamer element can be bound by either Oct-1 or Oct-2 but requires the expression of Oct-2 to activate transcription in B cells. Mutation of the octamer element renders the CD36 promoter refractory to activation by Oct-2. Furthermore, we demonstrate that the CD36 octamer element does not support recruitment of the B cell-specific co-activator OBF-1 and that CD36 expression is unaffected in primary B cells derived from obf-1–/– mice. We conclude that Oct-2 activates CD36 gene expression in mouse B cells via the octamer element in the promoter. Our data also demonstrate that CD36 is the first example of an Oct-2-dependent gene whose expression in B cells is independent of OBF-1. These findings support the notion that Oct-2 regulates gene transcription by both OBF-1-dependent and -independent mechanisms.

* To whom correspondence should be addressed. Tel: +44 161 275 5978; Fax: +44 161 275 5082; Email: paul.shore{at}man.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
P. L. Hayes, B. L. Lytle, B. F. Volkman, and F. C. Peterson
The solution structure of ZNF593 from Homo sapiens reveals a zinc finger in a predominately unstructured protein
Protein Sci., March 1, 2008; 17(3): 571 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Emslie, K. D'Costa, J. Hasbold, D. Metcalf, K. Takatsu, P. O. Hodgkin, and L. M. Corcoran
Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor {alpha} chain expression on activated B cells
J. Exp. Med., February 18, 2008; 205(2): 409 - 421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lau, S. J. Nixon, R. G. Parton, and G. E. O. Muscat
ROR{alpha} Regulates the Expression of Genes Involved in Lipid Homeostasis in Skeletal Muscle Cells: CAVEOLIN-3 AND CPT-1 ARE DIRECT TARGETS OF ROR
J. Biol. Chem., August 27, 2004; 279(35): 36828 - 36840.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Corcoran, F. Koentgen, W. Dietrich, M. Veale, and P. O. Humbert
All Known In Vivo Functions of the Oct-2 Transcription Factor Require the C-Terminal Protein Domain
J. Immunol., March 1, 2004; 172(5): 2962 - 2969.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. E. H. Wang, D. Tantin, J. Chen, and P. A. Sharp
B cell development and immunoglobulin transcription in Oct-1-deficient mice
PNAS, February 17, 2004; 101(7): 2005 - 2010.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. E. H. Wang, T. Schmidt, J. Chen, P. A. Sharp, and D. Tantin
Embryonic Lethality, Decreased Erythropoiesis, and Defective Octamer-Dependent Promoter Activation in Oct-1-Deficient Mice
Mol. Cell. Biol., February 1, 2004; 24(3): 1022 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. K. Inman and P. Shore
The Osteoblast Transcription Factor Runx2 Is Expressed in Mammary Epithelial Cells and Mediates osteopontin Expression
J. Biol. Chem., December 5, 2003; 278(49): 48684 - 48689.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. Dressel, T. L. Allen, J. B. Pippal, P. R. Rohde, P. Lau, and G. E. O. Muscat
The Peroxisome Proliferator-Activated Receptor {beta}/{delta} Agonist, GW501516, Regulates the Expression of Genes Involved in Lipid Catabolism and Energy Uncoupling in Skeletal Muscle Cells
Mol. Endocrinol., December 1, 2003; 17(12): 2477 - 2493.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Brunner, H. Laumen, P. J. Nielsen, N. Kraut, and T. Wirth
Expression of the Aldehyde Dehydrogenase 2-like Gene Is Controlled by BOB.1/OBF.1 in B Lymphocytes
J. Biol. Chem., November 14, 2003; 278(46): 45231 - 45239.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. A. P. Bristow and P. Shore
Transcriptional regulation of the human MIP-1{alpha} promoter by RUNX1 and MOZ
Nucleic Acids Res., June 1, 2003; 31(11): 2735 - 2744.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
L. Corcoran, D. Vremec, M. Febbraio, T. Baldwin, and E. Handman
Differential regulation of CD36 expression in antigen-presenting cells: Oct-2 dependence in B lymphocytes but not dendritic cells or macrophages
Int. Immunol., October 1, 2002; 14(10): 1099 - 1104.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.